UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) April 23, 2018
REPRO MED SYSTEMS, INC.
(Exact name of registrant as specified in its charter)
New York | 0-12305 | 13-3044880 |
(State or other jurisdiction | (Commission | (IRS Employer |
24 Carpenter Road, Chester, New York | 10918 |
(Address of principal executive offices) | (Zip Code) |
Registrant’s telephone number, including area code (845) 469-2042
not applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
ITEM 5.07 SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
Set forth below are the voting results from the 2018 Annual Meeting of Shareholders held on April 23, 2018:
PROPOSAL 1: ELECTION OF DIRECTORS
The nominees for director set forth under “Nominees” below were elected to the Company’s board of directors.
| NUMBER OF SHARES | ||
NOMINEES | FOR | WITHHELD | BROKER NON-VOTE |
Andrew I. Sealfon | 22,706,581 | 792,443 | 7,470,630 |
Paul M. Baker | 15,429,094 | 8,069,930 | 7,470,630 |
Mark L. Pastreich | 15,606,263 | 7,892,761 | 7,470,630 |
Arthur J. Radin | 23,439,239 | 59,785 | 7,470,630 |
David W. Anderson | 23,010,719 | 488,305 | 7,470,630 |
Joseph M. Manko, Jr. | 22,452,719 | 1,046,305 | 7,470,630 |
Daniel S. Goldberger | 23,455,719 | 43,305 | 7,470,630 |
PROPOSAL 2: ADVISORY VOTE - EXECUTIVE COMPENSATION
The Company’s shareholders approved, on an advisory basis, the compensation of the Company’s named executive officers.
| FOR | AGAINST | ABSTAIN | BROKER NON-VOTE |
Number of Shares | 20,327,536 | 1,404,341 | 1,767,147 | 7,470,630 |
PROPOSAL 3: RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTANTS
The Company’s shareholders ratified the appointment of McGrail Merkel Quinn & Associates, P.C. as the Company’s independent registered public accountants for the 2018 fiscal year.
| FOR | AGAINST | ABSTAIN |
Number of Shares | 29,524,404 | 92,266 | 1,352,984 |
- 2 -
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| REPRO MED SYSTEMS, INC. | |
|
|
|
Date: April 24, 2018 | By: | /s/ Andrew I. Sealfon |
| Andrew I. Sealfon | |
- 3 -